![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: SF3A1 |
Gene summary for SF3A1 |
![]() |
Gene information | Species | Human | Gene symbol | SF3A1 | Gene ID | 10291 |
Gene name | splicing factor 3a subunit 1 | |
Gene Alias | PRP21 | |
Cytomap | 22q12.2 | |
Gene Type | protein-coding | GO ID | GO:0000245 | UniProtAcc | A0A024R1K8 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
10291 | SF3A1 | C38 | Human | Oral cavity | OSCC | 2.65e-11 | 1.12e+00 | 0.172 |
10291 | SF3A1 | C43 | Human | Oral cavity | OSCC | 2.54e-22 | 5.46e-01 | 0.1704 |
10291 | SF3A1 | C46 | Human | Oral cavity | OSCC | 1.71e-19 | 5.03e-01 | 0.1673 |
10291 | SF3A1 | C51 | Human | Oral cavity | OSCC | 1.88e-16 | 7.65e-01 | 0.2674 |
10291 | SF3A1 | C57 | Human | Oral cavity | OSCC | 3.56e-21 | 5.87e-01 | 0.1679 |
10291 | SF3A1 | C06 | Human | Oral cavity | OSCC | 2.92e-07 | 8.90e-01 | 0.2699 |
10291 | SF3A1 | C08 | Human | Oral cavity | OSCC | 4.98e-15 | 4.53e-01 | 0.1919 |
10291 | SF3A1 | C09 | Human | Oral cavity | OSCC | 3.01e-02 | 1.50e-01 | 0.1431 |
10291 | SF3A1 | LN22 | Human | Oral cavity | OSCC | 2.56e-02 | 6.63e-01 | 0.1733 |
10291 | SF3A1 | LN38 | Human | Oral cavity | OSCC | 2.54e-03 | 7.38e-01 | 0.168 |
10291 | SF3A1 | LN46 | Human | Oral cavity | OSCC | 2.00e-12 | 6.99e-01 | 0.1666 |
10291 | SF3A1 | LP15 | Human | Oral cavity | LP | 4.17e-09 | 1.02e+00 | 0.2174 |
10291 | SF3A1 | LP17 | Human | Oral cavity | LP | 8.41e-03 | 5.07e-01 | 0.2349 |
10291 | SF3A1 | SYSMH1 | Human | Oral cavity | OSCC | 2.73e-09 | 2.77e-01 | 0.1127 |
10291 | SF3A1 | SYSMH2 | Human | Oral cavity | OSCC | 1.81e-14 | 4.01e-01 | 0.2326 |
10291 | SF3A1 | SYSMH3 | Human | Oral cavity | OSCC | 2.73e-17 | 5.10e-01 | 0.2442 |
10291 | SF3A1 | SYSMH5 | Human | Oral cavity | OSCC | 1.40e-06 | 2.99e-01 | 0.0647 |
10291 | SF3A1 | SYSMH6 | Human | Oral cavity | OSCC | 4.68e-03 | 1.94e-01 | 0.1275 |
10291 | SF3A1 | Dong_P1 | Human | Prostate | Tumor | 1.21e-11 | 5.65e-02 | 0.035 |
10291 | SF3A1 | Dong_P3 | Human | Prostate | Tumor | 6.42e-08 | 7.72e-02 | 0.0278 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:0008380 | Colorectum | AD | RNA splicing | 169/3918 | 434/18723 | 3.59e-18 | 2.04e-15 | 169 |
GO:0000377 | Colorectum | AD | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 130/3918 | 320/18723 | 5.88e-16 | 2.16e-13 | 130 |
GO:0000398 | Colorectum | AD | mRNA splicing, via spliceosome | 130/3918 | 320/18723 | 5.88e-16 | 2.16e-13 | 130 |
GO:0000375 | Colorectum | AD | RNA splicing, via transesterification reactions | 131/3918 | 324/18723 | 7.11e-16 | 2.22e-13 | 131 |
GO:0022618 | Colorectum | AD | ribonucleoprotein complex assembly | 92/3918 | 220/18723 | 1.49e-12 | 2.60e-10 | 92 |
GO:0071826 | Colorectum | AD | ribonucleoprotein complex subunit organization | 94/3918 | 227/18723 | 1.70e-12 | 2.87e-10 | 94 |
GO:0022613 | Colorectum | AD | ribonucleoprotein complex biogenesis | 151/3918 | 463/18723 | 1.96e-09 | 1.39e-07 | 151 |
GO:0000245 | Colorectum | AD | spliceosomal complex assembly | 33/3918 | 79/18723 | 2.15e-05 | 4.33e-04 | 33 |
GO:0006376 | Colorectum | AD | mRNA splice site selection | 18/3918 | 49/18723 | 7.93e-03 | 4.73e-02 | 18 |
GO:00083801 | Colorectum | SER | RNA splicing | 123/2897 | 434/18723 | 3.84e-12 | 8.41e-10 | 123 |
GO:00226181 | Colorectum | SER | ribonucleoprotein complex assembly | 69/2897 | 220/18723 | 2.25e-09 | 2.15e-07 | 69 |
GO:00718261 | Colorectum | SER | ribonucleoprotein complex subunit organization | 70/2897 | 227/18723 | 3.83e-09 | 3.51e-07 | 70 |
GO:00003751 | Colorectum | SER | RNA splicing, via transesterification reactions | 90/2897 | 324/18723 | 8.68e-09 | 7.50e-07 | 90 |
GO:00003771 | Colorectum | SER | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 89/2897 | 320/18723 | 9.82e-09 | 8.14e-07 | 89 |
GO:00003981 | Colorectum | SER | mRNA splicing, via spliceosome | 89/2897 | 320/18723 | 9.82e-09 | 8.14e-07 | 89 |
GO:00226131 | Colorectum | SER | ribonucleoprotein complex biogenesis | 112/2897 | 463/18723 | 5.01e-07 | 2.48e-05 | 112 |
GO:00083802 | Colorectum | MSS | RNA splicing | 159/3467 | 434/18723 | 1.75e-19 | 1.22e-16 | 159 |
GO:00003772 | Colorectum | MSS | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 121/3467 | 320/18723 | 2.52e-16 | 8.27e-14 | 121 |
GO:00003982 | Colorectum | MSS | mRNA splicing, via spliceosome | 121/3467 | 320/18723 | 2.52e-16 | 8.27e-14 | 121 |
GO:00003752 | Colorectum | MSS | RNA splicing, via transesterification reactions | 122/3467 | 324/18723 | 2.75e-16 | 8.58e-14 | 122 |
Page: 1 2 3 4 5 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa03040 | Colorectum | AD | Spliceosome | 73/2092 | 217/8465 | 1.73e-03 | 9.68e-03 | 6.18e-03 | 73 |
hsa030401 | Colorectum | AD | Spliceosome | 73/2092 | 217/8465 | 1.73e-03 | 9.68e-03 | 6.18e-03 | 73 |
hsa030402 | Colorectum | MSS | Spliceosome | 66/1875 | 217/8465 | 2.58e-03 | 1.27e-02 | 7.81e-03 | 66 |
hsa030403 | Colorectum | MSS | Spliceosome | 66/1875 | 217/8465 | 2.58e-03 | 1.27e-02 | 7.81e-03 | 66 |
hsa0304027 | Esophagus | ESCC | Spliceosome | 128/4205 | 217/8465 | 3.31e-03 | 8.79e-03 | 4.50e-03 | 128 |
hsa0304037 | Esophagus | ESCC | Spliceosome | 128/4205 | 217/8465 | 3.31e-03 | 8.79e-03 | 4.50e-03 | 128 |
hsa030407 | Liver | Cirrhotic | Spliceosome | 102/2530 | 217/8465 | 5.69e-08 | 9.47e-07 | 5.84e-07 | 102 |
hsa0304012 | Liver | Cirrhotic | Spliceosome | 102/2530 | 217/8465 | 5.69e-08 | 9.47e-07 | 5.84e-07 | 102 |
hsa0304022 | Liver | HCC | Spliceosome | 122/4020 | 217/8465 | 5.55e-03 | 1.60e-02 | 8.91e-03 | 122 |
hsa0304032 | Liver | HCC | Spliceosome | 122/4020 | 217/8465 | 5.55e-03 | 1.60e-02 | 8.91e-03 | 122 |
hsa0304016 | Oral cavity | OSCC | Spliceosome | 123/3704 | 217/8465 | 7.21e-05 | 2.74e-04 | 1.40e-04 | 123 |
hsa0304017 | Oral cavity | OSCC | Spliceosome | 123/3704 | 217/8465 | 7.21e-05 | 2.74e-04 | 1.40e-04 | 123 |
hsa0304026 | Oral cavity | LP | Spliceosome | 106/2418 | 217/8465 | 1.30e-10 | 2.40e-09 | 1.55e-09 | 106 |
hsa0304036 | Oral cavity | LP | Spliceosome | 106/2418 | 217/8465 | 1.30e-10 | 2.40e-09 | 1.55e-09 | 106 |
hsa0304025 | Prostate | Tumor | Spliceosome | 66/1791 | 217/8465 | 7.53e-04 | 3.59e-03 | 2.23e-03 | 66 |
hsa0304035 | Prostate | Tumor | Spliceosome | 66/1791 | 217/8465 | 7.53e-04 | 3.59e-03 | 2.23e-03 | 66 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
SF3A1 | SNV | Missense_Mutation | novel | c.2005C>A | p.Pro669Thr | p.P669T | Q15459 | protein_coding | tolerated(0.37) | probably_damaging(0.981) | TCGA-A7-A0DB-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | arimidex | SD |
SF3A1 | SNV | Missense_Mutation | c.1796N>A | p.Arg599Gln | p.R599Q | Q15459 | protein_coding | tolerated(0.68) | possibly_damaging(0.885) | TCGA-BH-A18G-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
SF3A1 | SNV | Missense_Mutation | c.1229A>G | p.Tyr410Cys | p.Y410C | Q15459 | protein_coding | deleterious(0) | possibly_damaging(0.608) | TCGA-D8-A1XK-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicine+cyclophosphamide | SD | |
SF3A1 | SNV | Missense_Mutation | novel | c.823G>T | p.Asp275Tyr | p.D275Y | Q15459 | protein_coding | deleterious(0) | probably_damaging(0.977) | TCGA-OK-A5Q2-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
SF3A1 | deletion | Frame_Shift_Del | novel | c.1452delT | p.Ile484MetfsTer17 | p.I484Mfs*17 | Q15459 | protein_coding | TCGA-EW-A2FV-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | docetaxel | SD | ||
SF3A1 | SNV | Missense_Mutation | novel | c.1798N>T | p.Pro600Ser | p.P600S | Q15459 | protein_coding | tolerated(0.08) | benign(0.118) | TCGA-A6-5665-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
SF3A1 | SNV | Missense_Mutation | rs377475726 | c.1904N>T | p.Ala635Val | p.A635V | Q15459 | protein_coding | tolerated(0.23) | benign(0.047) | TCGA-AA-3663-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
SF3A1 | SNV | Missense_Mutation | c.1497N>T | p.Lys499Asn | p.K499N | Q15459 | protein_coding | deleterious(0) | probably_damaging(0.95) | TCGA-AA-3811-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD | |
SF3A1 | SNV | Missense_Mutation | rs370505540 | c.509N>T | p.Thr170Met | p.T170M | Q15459 | protein_coding | tolerated(0.06) | probably_damaging(0.996) | TCGA-AA-3980-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
SF3A1 | SNV | Missense_Mutation | c.1289G>A | p.Arg430His | p.R430H | Q15459 | protein_coding | deleterious(0.01) | probably_damaging(0.991) | TCGA-AD-5900-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |